Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 351 (9105) , 773-780
- https://doi.org/10.1016/s0140-6736(97)03471-5
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Do patients with COPD benefit from treatment with inhaled corticosteroids?European Respiratory Journal, 1996
- Airways inflammationin asthma and chronic bronchitisClinical and Experimental Allergy, 1996
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- A comparison of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μg/day in adult asthmaAllergy, 1994
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993
- A Comparison of Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways DiseaseNew England Journal of Medicine, 1992
- Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.Thorax, 1991
- Corticosteroid trials in non-asthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate.Thorax, 1990
- Definitions of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium.Thorax, 1984
- The natural history of chronic airflow obstruction.BMJ, 1977